The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Open accessAbstract
BACKGROUND: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). OBJECTIVES: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. METHODS: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I² statistic, and conducted meta-analyses. RESULTS: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9% (95% CI: 8.76%-35.0%), while it was 14.8% for alcohol abuse, 5.83% for bipolar disorder, 23.7% (95% CI: 17.4%-30.0%) for depression, 2.5% for substance abuse, and 4.3% (95% CI: 0%-10.3%) for psychosis. CONCLUSION: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A comprehensive systematic review of 118 studies on psychiatric comorbidities in MS found that psychiatric comorbidities were common; in particular, the prevalence of diagnosed anxiety and depression were estimated at 21.9 and 23.7%, respectively [53].”
From Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap (2022) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“MS patients show increased levels of anxiety and depression compared to healthy participants, and these conditions affect more than 20% of patients [8,21,22,23].”
From Biopsychosocial Correlates of Quality of Life in Multiple Sclerosis Patients (2022) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Marrie, R., Cohen, J., Stüve, O., Trojano, M., Sørensen, P., Reingold, S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis · doi:10.1177/1352458514564491 · Cited by 762
Self-citationNeyeloff, J. L., Fuchs, S. C. P. C., & Moreira, L. B. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-52 · Cited by 731
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Depression and multiple sclerosis
Sadovnick, A. D., Remick, R. A., Allen, J. B., Swartz, E. S., Yee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, J. P., Kastrukoff, L. F., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.628 · Cited by 536
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700511 · Cited by 506
Quality of life in patients with multiple sclerosis
Janardhan, V., & Bakshi, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00312-x · Cited by 489
Lobentanz, I. S., Asenbaum, S., Vass, K., Sauter, C., Klosch, G., Kollegger, H., Kristoferitsch, W., & Zeitlhofer, J. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00257.x · Cited by 439
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424
Cited by
Sorted by citations
Items 101–200 of 519
Bidirectional communication between neural and immune systems
Kamimura, D., Tanaka, Y., Hasebe, R., & Murakami, M. (2019) · International Immunology · doi:10.1093/intimm/dxz083 · Cited by 46
Affective Temperament Profiles in Patients with Multiple Sclerosis: Association with Mood Disorders
Özkan, A., Altınbaş, K., Koç, E. R., Şen, H. M., & Karaman, H. İ. Ö. (2015) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2015.12393 · Cited by 38
Kim, S., Chung, A., Na, J. E., Lee, S. J., Jeong, S. H., Kim, E., Sun, W., Rhyu, I. J., & Park, H. (2019) · Glia · doi:10.1002/glia.23669 · Cited by 38
Screening Tools for Anxiety in People with Multiple Sclerosis
Litster, B., Fiest, K. M., Patten, S. B., Fisk, J. D., Walker, J. R., Graff, L. A., Bolton, J. M., Sareen, J., Marriott, J. J., Berrigan, L. I., et al. (2016) · International Journal of MS Care · doi:10.7224/1537-2073.2016-004 · Cited by 42
Self-citationHotier, S., Maltête, D., Bourre, B., Jegouzo, X., Bourgeois, V., & Guillin, O. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.07.002 · Cited by 37
Frahm, N., Hecker, M., & Zettl, U. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40283-5 · Cited by 40
Davis, B. E., Lakin, L., Binns, C. C., Currie, K. M., & Rensel, M. R. (2021) · Neurology and Therapy · doi:10.1007/s40120-021-00240-9 · Cited by 41
Bahrani, S., Zargar, F., Yousefipour, G., & Akbari, H. (2017) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.44566 · Cited by 36
Kołtuniuk, A., & Rosińćzuk, J. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.51172 · Cited by 36
Headache and Its Management in Patients With Multiple Sclerosis
Husain, F., Pardo, G., & Rabadi, M. H. (2018) · Current Treatment Options in Neurology · doi:10.1007/s11940-018-0495-4 · Cited by 36
Abrevaya, S., Fittipaldi, S., García, A. M., Dottori, M., Santamaria-Garcia, H., Birba, A., Yoris, A., Hildebrandt, M. K., Salamone, P., De la Fuente, A., et al. (2020) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000868 · Cited by 34
Moderators of Exercise Effects on Depressive Symptoms in Multiple Sclerosis: A Meta-regression
Herring, M. P., Fleming, K. M., Hayes, S., Motl, R. W., & Coote, S. B. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.04.011 · Cited by 35
Cognitive Behavioral Therapy for the Management of Multiple Sclerosis–Related Pain
Gromisch, E. S., Kerns, R. D., Czlapinski, R., Beenken, B., Otis, J., Lo, A. C., & Beauvais, J. (2020) · International Journal of MS Care · doi:10.7224/1537-2073.2018-023 · Cited by 34
Brenner, P., Granqvist, M., Königsson, J., Nimer, F. A., Piehl, F., & Jokinen, J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.002 · Cited by 34
Hernández-Ledesma, A. L., Rodríguez-Méndez, A. J., Gallardo-Vidal, L. S., Trejo-Cruz, G., García-Solís, P., & Dávila-Esquivel, F. D. J. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.06.001 · Cited by 31
The relationship between cognitive fusion, stigma, and well-being in people with multiple sclerosis
Valvano, A., Floyd, R. M., Penwell-Waines, L., Stepleman, L., Lewis, K., & House, A. (2016) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2016.07.003 · Cited by 32
Management of multiple sclerosis: the role of coping self-efficacy and self-esteem
Mikula, P., Nagyova, I., Vitkova, M., & Szilasiova, J. (2018) · Psychology, Health & Medicine · doi:10.1080/13548506.2018.1437277 · Cited by 33
Gunn, H., Cameron, M. H., Hoang, P. D., Lord, S. R., Shaw, S. R., & Freeman, J. A. (2018) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2018.03.019 · Cited by 33
Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis
Chertcoff, A. S., Yusuf, F. L. A., Zhu, F., Evans, C. D., Fisk, J. D., Zhao, Y., Marrie, R. A., & Tremlett, H. L. (2023) · Neurology · doi:10.1212/wnl.0000000000207843 · Cited by 31
Self-citationPrevalence, treatment and correlates of depression in multiple sclerosis
Young, C. A., Langdon, D. W., Rog, D. J., Chhetri, S. K., Tănăsescu, R., Kalra, S., Webster, G., Nicholas, R. S., Ford, H. L., Woolmore, J., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105648 · Cited by 32
Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study
O’Connell, K., Tubridy, N. J., Hutchinson, M., & McGuigan, C. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.02.010 · Cited by 32
Emotion dysregulation in multiple sclerosis: Impact on symptoms of depression and anxiety.
Prakash, R., Schirda, B., Valentine, T., Crotty, M., & Nicholas, J. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101399 · Cited by 33
Multiple Sclerosis and Autoimmune Comorbidities
Nociti, V., & Romozzi, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111828 · Cited by 32
Beswick, E., Quigley, S. M., Macdonald, P., Patrick, S. L., Colville, S., Chandran, S., & Connick, P. (2022) · BMC Psychology · doi:10.1186/s40359-022-00949-8 · Cited by 39
Psychiatric comorbidity in multiple sclerosis
Panda, S. P., Das, R., Srivastava, K., Ratnam, A., & Sharma, N. (2018) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2018.09.003 · Cited by 31
Lo, L. M. P., Taylor, B. V., Winzenberg, T. M., Palmer, A. J., Blizzard, L., & van der Mei, I. A. F. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10194-x · Cited by 31
The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data
Maric, G. D., Pekmezovic, T. D., Mesaroš, Š., Tamaš, O., Ivanović, J., Martinović, V., Andabaka, M., Jovanović, A., Veselinovic, N. D., Kisić-Tepavčević, D., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04727-5 · Cited by 31
Tzeng, N.-S., Chang, H.-A., Chung, C.-H., Lin, F.-H., Yeh, C., Huang, S.-Y., Chang, C.-C., Lu, R.-B., Kao, Y., Yeh, H.-W., et al. (2017) · Journal of Neurological Sciences · doi:10.1016/j.jns.2017.08.022 · Cited by 27
Li, Z., Chen, K., Shao, Q., Lu, H., Zhang, X., Pu, Y., Sun, X.-J., He, H., & Cao, L. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02696-y · Cited by 30
Fernández, V., Alonso, N., Melamud, L., & Villa, A. M. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.11.002 · Cited by 30
Barta, T., & Kiropoulos, L. A. (2022) · International Journal of Behavioral Medicine · doi:10.1007/s12529-022-10078-6 · Cited by 38
Battalio, S. L., Glette, M., Alschuler, K. N., & Jensen, M. P. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000231 · Cited by 30
Apweiler, M., Saliba, S. W., Sun, L., Streyczek, J., Normann, C., Hellwig, S., Bräse, S., & Fiebich, B. L. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02614-5 · Cited by 31
Internet-based treatment for depression in multiple sclerosis: A randomized controlled trial
Boeschoten, R., Dekker, J., Uitdehaag, B., Beekman, A., Hoogendoorn, A., Collette, E., Cuijpers, P., Nieuwenhuis, M. M., & van Oppen, P. (2017) · Multiple Sclerosis · doi:10.1177/1352458516671820 · Cited by 24
Menculini, G., Balducci, P. M., Attademo, L., Bernardini, F., Moretti, P., & Tortorella, A. A. V. (2020) · Medicina · doi:10.3390/medicina56120689 · Cited by 28
Menculini, G., Mancini, A., Gaetani, L., Bellingacci, L., Tortorella, A., Parnetti, L., & Filippo, M. D. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-329806 · Cited by 22
Jerković, A., Proroković, A., Matijaca, M., Vuko, J., Poljičanin, A., Mastelić, A., Katić, A. Ć., Košta, V., Kustura, L., Dolić, K., et al. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.794353 · Cited by 33
Maldonado, D. P., Eusebio, J. R., Amezcua, L., Vasileiou, E. S., Mowry, E. M., Hemond, C. C., Umeton, R. P., Morales, I. B., Radu, I., Ionete, C., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103451 · Cited by 27
Jiang, J., Abduljabbar, S., Zhang, C., & Osier, N. D. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104142 · Cited by 28
Palotai, M., Mike, A., Cavallari, M., Strammer, E., Orsi, G., Healy, B., Schregel, K., Illés, Z., & Guttmann, C. (2018) · Multiple Sclerosis · doi:10.1177/1352458517711273 · Cited by 29
Minnema, L. A., Giezen, T. J., Souverein, P. C., Egberts, T. C. G., Leufkens, H. G. M., & Gardarsdóttir, H. (2019) · Drug Safety · doi:10.1007/s40264-018-00789-9 · Cited by 28
Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis
Altmann, P., Leutmezer, F., Leithner, K., Monschein, T., Ponleitner, M., Stattmann, M., Rommer, P. S., Zrzavy, T., Zulehner, G., Berek, K., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.618370 · Cited by 27
Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder
Hollinger, K. R., Franke, C., Arenivas, A., Woods, S. R., Mealy, M. A., Levy, M., & Kaplin, A. I. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.01.010 · Cited by 27
Symptomatic management in multiple sclerosis
Shah, P. (2015) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.164827 · Cited by 26
Fernández-Muñóz, J. J., Cigarán‐Méndez, M., Navarro‐Pardo, E., Pérez‐de‐Heredia‐Torres, M., Parás‐Bravo, P., & Fernández‐de‐las‐Peñas, C. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016297 · Cited by 27
Symptom clusters and quality of life in persons with multiple sclerosis across the lifespan
Silveira, S. L., Cederberg, K. L. J., Jeng, B., Sikes, E. M., Sandroff, B. M., Jones, C. D., & Motl, R. W. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02689-x · Cited by 26
Vidaković, M. R., Šimić, N., Poljičanin, A., Ivanišević, M. N., Jerković, A., & Đogaš, Z. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102850 · Cited by 29
Thompson, B., Moghaddam, N., Evangelou, N., Baufeldt, A., & das Nair, R. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103862 · Cited by 25
Zhao, Z., Zhang, Y., Du, Q., Chen, H., Shi, Z., Wang, J., Qiu, Y., Yan, C., & Zhou, H. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102693 · Cited by 27
Association of personality traits with physical function, cognition, and mood in multiple sclerosis
Kever, A., Walker, E., Riley, C., Heyman, R. A., Xia, Z., & Leavitt, V. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103648 · Cited by 25
Ayatollahi, S. A., Hoseini, M. H. M., Ghanadian, M., Kosari‐Nasab, M., Mami, F., Yazdiniapoure, Z., Zolfaghari, B., & Salari, A. (2017) · Neurological Research · doi:10.1080/01616412.2017.1376789 · Cited by 25
Dehghani, A., & Keshavarzi, A. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.018 · Cited by 24
Models of Care in Multiple Sclerosis: A Survey of Canadian Health Providers
Marrie, R. A., Donkers, S. J., Jichici, D., Hrebicek, O., Metz, L. M., Morrow, S. A., Oh, J., Pétrin, J., Smyth, P. S., & Devonshire, V. A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.904757 · Cited by 24
Self-citationDevelopment of the Multiple Sclerosis Resiliency Scale (MSRS).
Gromisch, E. S., Sloan, J., Zemon, V. M., Tyry, T. M., Schairer, L. C., Snyder, S., & Foley, F. W. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000219 · Cited by 24
Alsaadi, T. M., Hammasi, K. E., Shahrour, T. M., Shakra, M., Turkawi, L., Nasreddine, W., Kassie, S. A., & Raoof, M. (2017) · Neurology International · doi:10.4081/ni.2017.7343 · Cited by 23
Glukhovsky, L., Kurz, D., Brandstadter, R., Leavitt, V. M., Krieger, S. C., Fabian, M. T., Sand, I. K., Klineova, S., Riley, C., LUBLIN, F. D., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520958359 · Cited by 23
Stein, C., O’Keeffe, F. M., Strahan, O., McGuigan, C., & Bramham, J. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105017 · Cited by 23
Psychiatric disorders in children with demyelinating diseases of the central nervous system
Pakpoor, J., Goldacre, R., Schmierer, K., Giovannoni, G., Waubant, E. L., & Goldacre, M. J. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517719150 · Cited by 23
Rintala, A., Matcham, F., Radaelli, M., Locafaro, G., Simblett, S. K., Pietro, C. B. D. S., Bulgari, V., Burke, P., Devonshire, J., Weyer, J., et al. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.109761 · Cited by 22
The Influence of Depression and Anxiety on Neurological Disability in Multiple Sclerosis Patients
Văcăraș, V., Văcăraș, V., Nistor, C., Văcăraș, D., Opre, A. N., Blaga, P., & Muresanu, D. F. (2020) · Behavioural Neurology · doi:10.1155/2020/6738645 · Cited by 23
Chronobiological regulation of psychosocial and physiological outcomes in multiple sclerosis
Somma, E. D., Jain, R. W., Poon, K. W. C., Tresidder, K. A., Segal, J. P., & Ghasemlou, N. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.011 · Cited by 21
Marrie, R. A., Walker, J. R., Graff, L. A., Patten, S. B., Bolton, J. M., Marriott, J. J., Fisk, J. D., Hitchon, C. A., PESCHKEN, C. A., & Bernstein, C. N. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2019.04.007 · Cited by 22
Self-citationMirabelli, E., & Elkabes, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.793745 · Cited by 23
Stiff-Person Syndrome and Psychiatric Comorbidities: A Systematic Review
Caffrey, D., Finn, C. T., Song, S. H., Burton, F., & Arsan, C. (2020) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.psym.2020.08.005 · Cited by 21
Zakibakhsh, N., Basharpoor, S., Langroodi, H. G., Narimani, M., Nitsche, M. A., & Salehinejad, M. A. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05638-1 · Cited by 23
Towards diagnostic markers for the psychoses
Lawrie, S. M., O’Donovan, M. C., Saks, E. R., Burns, T., & Lieberman, J. A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00021-3 · Cited by 21
Gromisch, E. S., Schairer, L. C., Pasternak, E., Kim, S. H., & Foley, F. W. (2016) · International Journal of MS Care · doi:10.7224/1537-2073.2016-007 · Cited by 21
Meier, U., Ramagopalan, S. V., Goldacre, M. J., & Goldacre, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00662 · Cited by 21
Biopsychosocial Correlates of Quality of Life in Multiple Sclerosis Patients
Batista, A. R., Silva, S., Lencastre, L., & Guerra, M. P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114431 · Cited by 20
Health-related quality of life in multiple sclerosis: temperament outweighs EDSS
Salhofer‐Polanyi, S., Friedrich, F., Löffler, S., Rommer, P. S., Gleiß, A., Engelmaier, R., Leutmezer, F., & Vyssoki, B. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1719-6 · Cited by 20
Current perspectives on co-morbid depression and multiple sclerosis
Patten, S. B. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1806062 · Cited by 20
Perceived social support, mental health, and marital satisfaction in multiple sclerosis patients
Özen, Ş., Karataş, T., & Polat, Ü. (2021) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12760 · Cited by 20
Th17-cells in depression: Implication in multiple sclerosis
Melnikov, M., & Lopatina, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010304 · Cited by 20
Behavioral Interventions in Multiple Sclerosis.
Turner, A. P., & Knowles, L. M. (2020) · PubMed · Cited by 23
The emotional disorders associated with multiple sclerosis
Raimo, S., Santangelo, G., & Trojano, L. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-822290-4.00009-8 · Cited by 20
Jun-O’connell, A., Butala, A., Morales, I., Henninger, N., Deligiannidis, K., Byatt, N., & Ionete, C. (2016) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.15120403 · Cited by 19
Sit less and move more: perspectives of adults with multiple sclerosis
Aminian, S., Ezeugwu, V. E., Motl, R. W., & Manns, P. J. (2017) · Disability and Rehabilitation · doi:10.1080/09638288.2017.1416499 · Cited by 19
Cognitive functioning and mental health in mitochondrial disease: A systematic scoping review
Klein, I., van de Loo, K. F. E., Smeitink, J. A. M., Janssen, M. C. H., Kessels, R. P. C., van Karnebeek, C., van der Veer, E., Custers, J. A. E., & Verhaak, C. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.004 · Cited by 20
Al‐Sakran, L., Marrie, R. A., Blackburn, D. F., Knox, K. B., & Evans, C. D. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.101955 · Cited by 18
Self-citationDatta, S., Suryadevara, U., & Cheong, J. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001051 · Cited by 21
Mediterranean Diet Reduces Social Isolation and Anxiety in Adult Female Nonhuman Primates
Johnson, C. S. C., Frye, B. M., Register, T. C., Snyder‐Mackler, N., & Shively, C. A. (2022) · Nutrients · doi:10.3390/nu14142852 · Cited by 18
Filser, M., Buchner, A., Fink, G. R., Gold, S. M., & Penner, I. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11359-6 · Cited by 18
Multiple sclerosis and anxiety: Is there an untapped opportunity for exercise?
Šilić, P., Motl, R. W., & Duffecy, J. L. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104698 · Cited by 18
Cognitive impairment in multiple sclerosis: “classic” knowledge and recent acquisitions
Piacentini, C., Argento, O., & Nocentini, U. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1763485 · Cited by 18
Alswat, A. M., Altirkistani, B. A., Alserihi, A. R., Baeshen, O. K., Alrushid, E. S., Alkhudair, J., Aldbas, A. A., Wadaan, O. M., Alsaleh, A., Malik, Y. M. A., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1195101 · Cited by 18
Reilly, G. D., Mahkawnghta, A. S., Jelinek, P. L., Livera, A. M. D., Weiland, T. J., Brown, C. R., Taylor, K. L., Neate, S. L., Jelinek, G. A., & Marck, C. H. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00229 · Cited by 18
Malivoire, B. L., Hare, C. J., & Hart, T. L. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000180 · Cited by 18
Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden
Castelo‐Branco, A., Chiesa, F., Bengtsson, C., Lee, S., Minton, N., Niemcryk, S. J., Lindholm, A., Rosenlund, M., Piehl, F., & Montgomery, S. (2020) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217320947761 · Cited by 20
Palotai, M., Wallack, M., Kujbus, G., Dalnoki, A., & Guttmann, C. R. G. (2021) · JMIR mhealth and uhealth · doi:10.2196/19564 · Cited by 18
Ehde, D. M., Alschuler, K. N., Sullivan, M. D., Molton, I. R., Ciol, M. A., Bombardier, C. H., Curran, M. C., Gertz, K. J., Wundes, A., & Fann, J. R. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.10.001 · Cited by 17
Barriers and motivators for tobacco smoking cessation in people with multiple sclerosis
Hunter, A., Grech, L., Borland, R., das Nair, R., White, S. L., & Marck, C. H. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103085 · Cited by 17
Anxiety is more important than depression in MS – Yes
Morrow, S. A. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517751652 · Cited by 17
Chitnis, T., Vandercappellen, J., King, M., & Brichetto, G. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00368-2 · Cited by 19
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis
Gilio, L., Fresegna, D., Gentile, A., Guadalupi, L., Sanna, K., Vito, F. D., Balletta, S., Caioli, S., Rizzo, F. R., Musella, A., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105817 · Cited by 17
Social phobia in immune-mediated inflammatory diseases
Reinhorn, I. M., Bernstein, C. N., Graff, L. A., Patten, S. B., Sareen, J., Fisk, J. D., Bolton, J. M., Hitchon, C. A., & Marrie, R. A. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.109890 · Cited by 18
Self-citationSerum vitamin d inversely correlates with depression scores in people with multiple sclerosis
El‐Salem, K., Khalil, H. W., Al‐Sharman, A., Al-Mistarehi, A.-H. W., Yassin, A., Al‐Hayk, K., Qawasmeh, M. A., Bashayreh, S. Y., Kofahi, R. M., & Obeidat, A. Z. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102732 · Cited by 16
Psychiatric Advice During COVID-19 Pandemic for Patients with Multiple Sclerosis
Ahadi, M. S., Sahraian, M. A., Rezaeimanesh, N., & Moghadasi, A. N. (2020) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.103243 · Cited by 15
Depression is associated with disconnection of neurotransmitter-related nuclei in multiple sclerosis
Martino, M., Magioncalda, P., Mendili, M. E. E., Droby, A., Paduri, S., Schiavi, S., Petracca, M., & Inglese, M. (2020) · Multiple Sclerosis · doi:10.1177/1352458520948214 · Cited by 12
Effects of Robot-Assisted Gait Training in Patients With Multiple Sclerosis
Özsoy-Ünübol, T., Ata, E., Cavlak, M., Demir, S., Candan, Z., & Yılmaz, F. (2021) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001913 · Cited by 15
Cuerda‐Ballester, M., Martínez‐Rubio, D., García-Pardo, M. P., Proaño, B., Cubero-Plazas, L., Calvo-Capilla, A., Sancho-Cantus, D., & Ortí, J. E. D. L. R. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021387 · Cited by 15
Metadata
- Authors
- Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N.
- Affiliations
- University of Manitoba (CA)
- Scientific and Clinical Review Associates, LLC, USA
- Cleveland Clinic (US)
- Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA
- Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy
- Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark
- University of Alabama at Birmingham (US)
- Corresponding author
- Marrie, Ruth Ann
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2015-01-12
- Volume
- 21
- Issue
- 3
- Pages
- 305-317
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- PMC
- PMC4429164
- OpenAlex
- W2105913548
- Cited by
- 519
- References
- 136
- Citations by year
- 2026: 42 · 2025: 31 · 2024: 45 · 2023: 46 · 2022: 52 · 2021: 68 · 2020: 48 · 2019: 38 · 2018: 43 · 2017: 47 · 2016: 43 · 2015: 16
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Multiple Sclerosis Journal (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- mediaTUM (Technical University of Munich) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- U.S. Department of Defense
- National Multiple Sclerosis Society
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- Cleveland Clinic
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- MedDay Pharmaceuticals
- National Institutes of Health
- Genentech
- EMD Serono
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, psychiatric comorbidity, depression, anxiety, alcohol abuse, bipolar disorder, substance abuse, psychosis, incidence, prevalence, quality of life, fatigue
- MeSH terms
- Mental Disorders, Humans, Multiple Sclerosis, Comorbidity, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
